<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Oncogenic KRAS signaling is dysregulated in a three-dimensional (3D)-specific manner in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) HCT116 cells </plain></SENT>
<SENT sid="1" pm="."><plain>However, the identity of the crucial genes which are down-regulated through oncogenic KRAS in 3D cultures remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: We established a specific anti-alpha-kinase 2 (ALPK2) antibody and addressed the ALPK2 function in HKe3 cells, which are HCT116 cells with a disruption in oncogenic KRAS, in a 3D colonic-crypt model </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In HKe3 cells grown in 3D culture, ALPK2 siRNA inhibited <z:chebi fb="2" ids="8069">luminal</z:chebi> <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and reduced the expression of cleaved caspase-3 </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, ALPK2 siRNA reduced the expression of DNA repair genes </plain></SENT>
<SENT sid="5" pm="."><plain>Reduced expression of ALPK2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> was found to be correlated with clinical colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> in a public dataset of gene expression analyses </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: ALPK2, down-regulated by oncogenic KRAS, is crucial for <z:chebi fb="2" ids="8069">luminal</z:chebi> <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and expression of DNA repair-related genes, possibly in the transition of <z:mpath ids='MPATH_458'>normal</z:mpath> colonic crypt to <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
</text></document>